Presbyterian St. Luke's/Colorado Blood Cancer Institute — Denver, Colorado

Presbyterian St. Luke's/Colorado Blood Cancer Institute is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Presbyterian St. Luke's/Colorado Blood Cancer Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hematologic Malignancies, Inherited Disorders of Metabolism, Inherited Abnormalities of Platelets.

Sponsors: Center for International Blood and Marrow Transplant Research.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Denver

Browse all research sites in Colorado · View every site in Denver

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Presbyterian St. Luke's/Colorado Blood Cancer Institute?

Presbyterian St. Luke's/Colorado Blood Cancer Institute has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Presbyterian St. Luke's/Colorado Blood Cancer Institute conducted?

Presbyterian St. Luke's/Colorado Blood Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Hematologic Malignancies, Inherited Disorders of Metabolism, Inherited Abnormalities of Platelets.

Is Presbyterian St. Luke's/Colorado Blood Cancer Institute accredited by Crixeo Clinical Trials?

Presbyterian St. Luke's/Colorado Blood Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Presbyterian St. Luke's/Colorado Blood Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.